ADAGIO MEDICAL HOLDINGS, INC. Increase (Decrease) in Accounts Receivable
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Increase (Decrease) in Accounts Receivable of $17.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $17.00K.
- ADAGIO MEDICAL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.00K.
- ADAGIO MEDICAL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $2.00K.
- ADAGIO MEDICAL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was -$5.00K, a 102.96% decline year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$38.00K.
- ADAGIO MEDICAL HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $70.00K.
| Period end | Increase (Decrease) in Accounts Receivable 2 month | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 5 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 7 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-12 | $16.00K derived: sum of 2 quarters · filed 2026-05-12 | $18.00K derived: sum of 3 quarters · filed 2026-05-12 | $13.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.00K derived: sum of 2 quarters · filed 2026-03-27 | -$4.00K derived: sum of 3 quarters · filed 2026-08-11 | -$38.00K 10-K · filed 2026-03-27 | |||
| 2025-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.00K derived: sum of 2 quarters · filed 2026-08-11 | -$37.00K 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$39.00K 10-Q · filed 2026-08-11 | |||||
| 2025-03-31 | -$34.00K 10-Q · filed 2026-05-12 | ||||||
| 2024-12-31 | -$67.00K 10-K · filed 2026-03-27 | ||||||
| 2024-09-30 | -$15.00K 10-Q · filed 2025-11-12 | ||||||
| 2024-07-30 | $32.00K 10-K · filed 2026-03-27 | ||||||
| 2024-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $99.00K 10-Q · filed 2025-08-14 | $96.00K derived: sum of 3 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$70.00K 10-Q · filed 2025-05-15 | -$73.00K derived: sum of 2 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $70.00K 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $73.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |